Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsThe escalating demand for highly specific and efficacious therapeutic and diagnostic agents has driven significant advancements in antibody engineering. Monoclonal antibodies (mAbs) have revolutionized modern medicine, particularly in oncology, autoimmune diseases, and infectious disease management. While various methods exist for mAb generation, the discovery of fully human monoclonal antibodies remains a paramount objective due to their reduced immunogenicity, enhanced effector functions, and superior clinical safety profiles.
Phage display technology has emerged as a cornerstone in human monoclonal antibody discovery, offering an unparalleled capacity to screen vast combinatorial libraries of antibody fragments. This methodology links genotype to phenotype, allowing for the rapid selection of high-affinity binders from billions of unique variants. Leveraging the power of this technology, Creative Biolabs is at the forefront of providing comprehensive Human Monoclonal Antibody Discovery Services, designed to address the most challenging aspects of therapeutic antibody development. Our commitment to scientific rigor, technical precision, and innovative solutions positions us as a premier partner for researchers and biopharmaceutical companies seeking next-generation human antibody therapeutics.
Creative Biolabs offers an unparalleled suite of services for human monoclonal antibody discovery via phage display, tailored to meet the exact demands of modern drug development and fundamental research. Our comprehensive approach ensures the delivery of highly specific, high-affinity human antibodies, from initial antigen design to lead candidate identification and optimization.
Our core services in this area include:
Unlock a faster, more cost-effective path to high-affinity human antibodies with Creative Biolabs' extensive collection of premade phage display libraries. Bypass the time-consuming library construction phase and dive straight into high-success-rate screening. Our high-capacity (>2.1x1011) human antibody libraries enable efficient discovery against a wide array of targets—from proteins and cells to specific epitopes—perfectly suited for immunotherapy applications like CAR-T and ADCs. Save time and reduce costs while securing high-quality, developable antibodies.
The foundation of our service is the generation of high-quality, highly diverse human antibody libraries.
| Library Type | Human Naïve Antibody Library | Human Synthetic Antibody Library | Human Disease-Specific Antibody Library | ||
| Source | Derived from a broad pool of healthy human donors. | Fully synthetic, created by incorporating vast diversity into a custom-designed library. | Sourced from Peripheral Blood Mononuclear Cells (PBMCs) of individuals with specific immune responses (e.g., cancer patients). | ||
| Clonal Diversity | Provides vast and unbiased representation of the human antibody repertoire. | Customizable to target specific antigens with a vast array of potential antibody candidates. | Contains naturally matured, high-affinity antibodies generated during a physiological immune response. | ||
| Application Focus | Ideal for novel binder discovery, especially for wide range of targets, including unknown or poorly characterized ones. | Best for targeted therapeutics, offering flexibility in fine-tuning affinity, specificity, and stability. | Targets disease-specific profiles, particularly for high-affinity antibodies in therapeutic applications. |
Our robust screening platform is designed for the efficient isolation of high-affinity, specific binders. This involves multiple rounds of selection under progressively stringent conditions, ensuring optimal enrichment. We utilize diverse screening methodologies:
Selected antibody clones undergo rigorous validation to confirm binding affinity, specificity, and initial functional properties using a suite of advanced analytical techniques.
Our Human Monoclonal Antibody Discovery Service follows a meticulously structured yet adaptable workflow, ensuring transparency and efficiency from project initiation to deliverable submission. This proven pipeline integrates advanced technologies at each critical juncture, guaranteeing optimal outcomes.
| Step | Item | Description |
| 1 | Project Intake & Consultation | Our PhD-level scientists engage in in-depth discussions to define clear objectives. |
| 2 | Target Design and Preparation | We work closely with clients to confirm target information and support target preparation and activity validation. Our focus is on optimizing challenging targets to ensure effective screening and achieve project-specific results. |
| 3 |
Phage Display Library Construction Or Premade Human Antibody Libraries |
Ethically sourced PBMC samples Customized library design (naïve or synthetic) Antibody gene cloning and preparation High-capacity library construction (from 108 to 1011) |
| 4 | Phage Display Library Screening | Utilizing our advanced phage display platform, we conduct multiple rounds of biopanning against your target of interest. This high-throughput screening process is iteratively refined with increasing stringency to enrich for antibodies with high specificity and affinity. |
| 5 | Binder Validation | Following successful screening, individual antibody candidates are validated for specific binding. Crucially, we could employ Sequencing Platform, powered by Next-Generation Sequencing (NGS), to comprehensively identify and characterize all promising antibody sequences from enriched pools. |
| 6 | Antibody Production | For validated binders, we offer small-scale pilot production to assess expression and binding activity. |
| 7 | Antibody Characterization | Our capabilities extend to comprehensive functional characterization (including binding affinity, specificity, cross-reactivity, neutralization, blocking, stability, and in vitro efficacy). |
| 8 | Antibody Engineering | Once your high-affinity human antibodies are discovered, we offer comprehensive Antibody Engineering services. We can further enhance their therapeutic potential through affinity maturation, stability improvement, and engineering into advanced formats like bispecific antibodies or Antibody-Drug Conjugates (ADCs), ensuring optimal performance for your downstream applications. |
Creative Biolabs' leadership in human monoclonal antibody discovery is underpinned by a robust, integrated platform incorporating state-of-the-art technologies and proprietary methodologies. Our commitment to innovation ensures that our partners benefit from the most advanced tools available.
| Highly Customized Synthetic Library Construction | ||||||||
| Objective: We constructed a high-quality synthetic antibody library, tailored specifically to the client's needs, with randomization focused on the CDRH3 region. The library was designed to ensure a large library capacity and optimal diversity for effective screening. | ||||||||
Key Results:
|
| Antibody Discovery for Disease-Related Targets Using Premade Human scFv Library Screening | |
| Objective | The goal was to leverage our advanced premade human scFv library to identify high-affinity antibodies targeting a disease-related protein. The antibodies were meticulously selected for their specificity, ensuring they bind exclusively to the target protein and not to similar control proteins. |
| Starting Materials |
Biotinylated disease-related target protein T1 Control protein C1 |
| Screening Strategy |
In-solution screening using biotinylated target protein T1 4 rounds of screening followed by binder validation |
| Key Results |
 
|
| Antibody Discovery for MHC-Peptide Complexes via Premade Human scFv Library | |
| Objective | We were constructed to identify high-affinity human antibodies targeting an MHC-peptide complex using our premade human scFv library. We aimed to specifically isolate antibodies that bind to the target MHC-peptide complex, while avoiding non-specific binding to control MHC-peptide complexes. |
| Starting Materials |
Biotinylated MHC-peptide complex (target) Biotinylated control MHC-peptide complex Control MHC-peptide |
| Screening Strategy |
Pre-counter selection using biotinylated control MHC-peptide to remove non-specific binders. Positive selection for biotinylated target MHC-peptide, with the control MHC-peptide used as a competitor to further eliminate non-target binders. |
| Key Results |
 
|
Choosing Creative Biolabs for your human monoclonal antibody discovery project offers distinct advantages rooted in our scientific rigor, technological prowess, and client-centric approach.
Contact us immediately to discuss your specific needs with our expert team and embark on your next breakthrough discovery!
Beyond our core Human Monoclonal Antibody Discovery Services, Creative Biolabs offers a comprehensive species list of related capabilities to further advance your antibody development programs:
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
